Related Experiment Video
Updated: May 23, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Reversible dysphasia and statins.
1Department of Psychiatry, University of Wollongong, New South Wales, Australia. alienist@ihug.com.au
This study reports a case of reversible dysphasia linked to atorvastatin and rosuvastatin. The findings emphasize the importance of understanding drug interactions and reporting side effects.
Area of Science:
- Pharmacology
- Clinical Neurology
Background:
- Drug-induced dysphasia is a rare adverse effect.
- Statins, like atorvastatin and rosuvastatin, are commonly prescribed for hyperlipidemia.
- Indapamide is a diuretic often used in combination therapy.
Observation:
- A patient experienced reversible dysphasia while taking atorvastatin and indapamide.
- A similar, milder dysphasia recurred upon switching to rosuvastatin.
- Symptoms resolved after discontinuing rosuvastatin.
Findings:
- This case suggests a potential link between statin use (atorvastatin, rosuvastatin) and reversible dysphasia.
- The cytochrome P450 system may be involved in this drug interaction.
- Clinical examination confirmed the presence and resolution of dysphasia.
Implications:
- Highlights the need for greater awareness of statin-induced neurological side effects.
- Underscores the importance of considering drug interactions, particularly via the CYP450 pathway.
- Emphasizes the necessity of thorough patient reporting and clinical investigation of adverse drug reactions.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Alzheimer's Disease: Treatment
Coronary Artery Disease V: Interprofessional Care
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
